ESG

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

The Federation of Thai Industries' support for IME 2026 creates a vital platform for China-Thailand tech exchange, accelerating the region's digital shift.

A new partnership aims to reshape Australia's booming solar storage sector, bringing advanced all-in-one solutions to homes and installers nationwide.

Avnet's new integration facility in Singapore is more than a building; it's a strategic move in the global shift to diversify tech supply chains beyond China.

With 323 million seniors and a market set to hit ¥30 trillion, China's government is courting global innovators in elderly care. AID 2026 is the gateway.

On Red Dress Day, Métis leaders passed a sacred trust to PM Carney, demanding an end to funding gaps and real action on the stalled MMIWG2S+ crisis.

The beef giant's record R$57 billion annual revenue signals resilience, even as missed earnings and trade headwinds present complex challenges ahead.

Facing financial pressures, the biotech divests a key cancer program, repays debt, and now explores all options to maximize value for its remaining pipeline.

The environmental services firm posted sequential growth and cut costs, signaling a strategic pivot despite a year-over-year revenue dip.

Aptar Pharma and the FDA lead a critical mission to reinvent respiratory medicine, ensuring patient safety while tackling the climate impact of inhalers.

The chipmaker topped Q1 estimates and eyes a strong Q2, fueled by EV and AI markets, even as restructuring charges weigh on its bottom line.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.

With its stock at an all-time high, Ross Stores' upcoming earnings will be a critical test for the off-price sector's resilience and consumer spending.

As Talphera preps its Q1 update, all eyes are on its breakthrough drug Niyad® and the mounting costs of bringing a potential game-changer to market.

With a May 22 deadline, conservation groups are racing to apply for a share of $160 million dedicated to protecting Minnesota's natural legacy.

A merger of two innovation hubs, backed by industry giants, forms the Novara Energy Alliance to tackle the region's pressing energy and water crises.

A new AI-powered technology can spot deadly high potassium levels using a simple smartwatch ECG, a breakthrough that could transform remote patient care.

Dr. David Rankey joins Wellvana as CMO, a strategic move as the company scales its model and the industry shifts from proof of concept to performance.